QUAQUARINI, ERICA
 Distribuzione geografica
Continente #
NA - Nord America 461
EU - Europa 354
AS - Asia 56
AF - Africa 1
Totale 872
Nazione #
US - Stati Uniti d'America 459
IE - Irlanda 134
IT - Italia 134
FI - Finlandia 29
CN - Cina 25
DE - Germania 24
SE - Svezia 18
SG - Singapore 16
JP - Giappone 8
BE - Belgio 7
GB - Regno Unito 3
CA - Canada 2
CZ - Repubblica Ceca 2
IN - India 2
VN - Vietnam 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
GR - Grecia 1
ID - Indonesia 1
LT - Lituania 1
MU - Mauritius 1
SA - Arabia Saudita 1
Totale 872
Città #
Chandler 154
Dublin 134
New York 38
Ashburn 29
Helsinki 29
Boardman 21
Lawrence 18
Medford 18
Princeton 18
Shanghai 16
Milan 13
Wilmington 11
Ann Arbor 8
Singapore 8
Tokyo 8
Bari 7
Beijing 7
Brussels 7
Catania 7
Cagliari 6
Los Angeles 6
Palermo 6
Rome 6
Dallas 5
Florence 5
Pavia 5
Castellana Grotte 4
Norwalk 4
Angri 3
Padova 3
Rosarno 3
Santa Maria Nuova 3
Acqui Terme 2
Bergamo 2
Brescia 2
Brno 2
Chicago 2
Comiso 2
Ercolano 2
Faenza 2
Falkenstein 2
Fisciano 2
Maletto 2
Messina 2
Montefano 2
Naples 2
Olginate 2
Piedimulera 2
Pune 2
Redwood City 2
Reggio Emilia 2
Terni 2
Trento 2
Washington 2
Woodbridge 2
Alcamo 1
Athens 1
Berlin 1
Buffalo 1
Casamassima 1
Des Moines 1
Dong Ket 1
Dubai 1
Edmonton 1
Fairfield 1
Forest City 1
Gieboldehausen 1
Guangzhou 1
Gunzenhausen 1
Hangzhou 1
Hanoi 1
Jacksonville 1
Jakarta 1
Misterbianco 1
Montereale Valcellina 1
Ottawa 1
Parma 1
Piscataway 1
Redmond 1
Riyadh 1
Rockville 1
San Francisco 1
Santa Clara 1
Santa Maria a Vico 1
Seattle 1
Tremestieri Etneo 1
Treviso 1
Totale 688
Nome #
FATTORI CLINICI DI EFFICACIA DELLE TERAPIE IMMUNOTERAPICHE ANTI-PD-1/PD-L1 IN PAZIENTI AFFETTI DA CARCINOMA POLMONARE NON A PICCOLE CELLULE IN STADIO AVANZATO: STUDIO REAL-LIFE MULTICENTRICO 169
Uncommon dihydropyrimidine dehydrogenase mutations and toxicity by fluoropyrimidines: A lethal case with a new variant 52
Small bowel adenocarcinomas featuring special at-rich sequence-binding protein 2 (Satb2) expression and a colorectal cancer-like immunophenotype: A potential diagnostic pitfall 49
Poorly Cohesive Carcinoma of the Nonampullary Small Intestine: A Distinct Histologic Subtype with Prognostic Significance 47
Prognostic Value of 18 F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel 45
Patterns of treatment and outcome of palbociclib plus endocrine therapy in hormone receptor-positive/HER2 receptor-negative metastatic breast cancer: a real-world multicentre Italian study 45
Eribulin across multiple lines of chemotherapy: A retrospective study on quality of life and efficacy in metastatic breast cancer patients 45
Bilateral Breast Metastases from Epstein-Barr Virus-Associated Gastric Cancer during Pregnancy: Is There a Method to Its Madness? 43
PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability 43
Palbociclib in metastatic breast cancer: Current evidence and real-life data 42
Correction: PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability 41
Role of androgen receptor expression in early stage ER+/PgR−/HER2– breast cancer 41
Nivolumab induced thyroid dysfunction: Unusual clinical presentation and challenging diagnosis 37
Vinflunine in Advanced Transitional Cell Cancer of the Urothelial Tract: A Potential Option for Maintenance Therapy? A Case Series 34
Eribulin Treatment in Patients with Liver Metastatic Breast Cancer: Eight Italian Case Reports 34
Impact of COVID-19 outbreak on cancer patient care and treatment: Data from an outpatient oncology clinic in Lombardy (Italy) 33
Advanced salivary gland carcinoma expressing androgen receptor and HER2: targeted therapies first? 32
Patterns of treatment and outcome with 500-mg fulvestrant in postmenopausal women with hormone receptor-positive/HER2-negative metastatic breast cancer: a real-life multicenter Italian experience 30
Clinical and Biological Variables Influencing Outcome in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Anti-PD-1/PD-L1 Antibodies: A Prospective Multicentre Study 23
Claudin-18 expression in small bowel adenocarcinoma: a clinico-pathologic study 20
Totale 905
Categoria #
all - tutte 4.578
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.578


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202016 0 0 0 0 0 0 3 2 5 0 4 2
2020/202121 5 0 1 0 1 1 3 3 0 0 3 4
2021/2022108 1 0 15 1 0 2 0 4 6 17 11 51
2022/2023396 37 42 10 34 18 40 2 23 158 3 12 17
2023/2024277 37 34 20 15 23 68 14 18 1 7 15 25
2024/202587 31 35 21 0 0 0 0 0 0 0 0 0
Totale 905